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The mature capillary network, comprised of a quiescent endothelial cell 
monolayer, utilizes tight cell-cell interactions to maintain vascular stability and limit 
vascular leak.  An essential component of these intercellular contacts is the adherens 
junction protein vascular endothelial cadherin (VE-cadherin).  In multiple disease settings 
such as macular degeneration, sepsis, and pandemic influenza, the endothelium is 
activated and destabilized by cytokines such as vascular endothelial growth factor 
(VEGF), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α).  While an innate 
immune response is necessary to combat infection, an exuberant cytokine release can 
paradoxically injure the host endothelium, resulting in vascular damage, tissue edema, 
and death.  
In this dissertation we demonstrate that an endogenous, endothelial-specific 
Roundabout (Robo), Robo4, maintains vascular stability and quiescence.  Administration 
of Slit, an endogenous activator of Robo receptors, strengthens endothelial barrier 
function and limits vascular leak in a Robo4-dependent manner.  Furthermore, Slit 
treatment enhanced survival during sepsis and avian flu infection, diseases both 
characterized by hypercytokinemia.  We also discovered that Slit strengthens the vascular 
barrier by increasing VE-cadherin localization at the cell surface.  Slit also increases 
p120-catenin localization at the cell surface and enhances the interaction of p120-catenin 
with VE-cadherin, preventing the internalization of VE-cadherin.  Furthermore, Robo4 
activation leads to the recruitment of a paxillin-GIT1 signaling module that inactivates 
Arf6.  Arf6 plays a known role in regulating endocytic recycling, thus perhaps defining 
Robo4-dependent Slit signaling as a paxillin-GIT1-Arf6-p120-catenin-VE-cadherin 
stabilization pathway.   
Our studies fundamentally demonstrate that by specifically blunting the vascular 
response to hypercytokinemia, mortality can be reduced during severe experimental 
infections.  Activation of a vascular stabilizing pathway such as Robo4 may therefore 
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ENDOGENOUS ENDOTHELIAL CELL SIGNALING  
SYSTEMS MAINTAIN VASCULAR STABILITY 
 The following chapter is a reprint of a manuscript that Kevin Whitehead, Dean Li, 
and I co-authored for Angiogenesis.  It was published in 2009, volume 12 (2), pages 149-














































TARGETING ROBO4-DEPENDENT SLIT SIGNALING  
TO SURVIVE THE CYTOKINE STORM 
IN SEPSIS AND INFLUENZA 
 The following chapter is a reprint of a manuscript published in Science 
Translational Medicine.  It was published March 17, 2010, volume 2 (23), 23ra19, DOI: 
10.1126/scitranslmed.3000678.  In addition to myself, the other authors were Weiquan 
Zhu, Fernando Bozza, Matthew Smith, Dan Greif, Lise Sorensen, Luming Chen, Yuuki 
Kaminoh, Aubrey Chan, Samuel Passi, Craig Day, Dale Barnard, Guy Zimmerman, Mark 
Krasnow, and Dean Li.  I participated in the design, execution, interpretation of data, and 










































































SLIT2-ROBO4 SIGNALLING PROMOTES VASCULAR   
STABILITY BY BLOCKING ARF6 ACTIVITY 
 The following chapter is a reprint of a manuscript published in Nature Cell 
Biology.  It was published November 2009, volume 11 (11): pages 1325-1331. Epub 
October 18, 2009.  In addition to myself, the other authors were Chris Jones, Nayouki 
Nishiya, Weiquan Zhu, Lise Sorensen, Aubrey Chan, C. James Lim, Hayou Chen, 
Qisheng Zhang, Peter Schultz, Alaa Hayallah, Kirk Thomas, Michael Famulok, Kang 
Zhang, Mark Ginsberg, and Dean Li.  I participated predominantly in the design, 

























































The findings presented in this dissertation add two major contributions.  First, 
these data provide proof of principle that survival can be enhanced in sepsis and 
pandemic influenza by specifically blunting the vascular response to hypercytokinemia1.  
This was achieved without significantly dampening the cytokine immune response and 
without directly affecting the inflammatory cells, both likely important mediators in 
clearing an infection.  The vascular stabilizing effect of Slit in vivo was lost in 
Robo4AP/AP mice or in the presence of a VE-cadherin blocking antibody, further 
demonstrating the vascular specific effect of Slit.  Therefore, blunting the vascular 
response of the host to hypercytokinemia may provide a broad platform for treating 
multiple infectious threats characterized by an exuberant cytokine response.  
Current medical therapies target individual pathogens using vaccines and anti-
microbial agents.  These approaches have proven very effective.  However, vaccines for 
example take time to generate after isolating the pandemic agent and infectious agents are 
prone to developing resistance to current anti-microbial drugs2,3.  Thus the need for 
generating a broad approach is real.  One would imagine that instead of replacing current 
medical therapies, that the approach defined in this dissertation would be used in 
combination.  Perhaps the combination of these two approaches would result in  
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synergistic therapeutic efficacy, a hypothesis that still needs to be validated in animal 
models. 
In moving forward, it is important to note that additional endogenous vascular 
stabilizing systems have been defined including Angiopoietin/Tie2, Delta-like 4/Notch, 
and Sphingosine 1-phosphate/Sphingosine 1-phosphate receptor4,5.  The conclusions 
defined in this dissertation suggest that in addition to Robo4-dependent Slit signaling, 
these other systems warrant further investigation as therapeutics for pandemic infection 
characterized by hypercytokinemia.  Indeed, efficacy of Angiopoietin has already been 
demonstrated in endotoxic shock6.  In utilizing these various pathways, one may predict 
varying degrees of potency and efficacy, thus it will be important to determine which is 
most efficacious in developing a target for future clinical application.  This investigation 
should entail infectious settings such as hemorrhagic fever, cerebral malaria, and severe 
acute respiratory syndrome (SARS).  It would be interesting to see if these other 
stabilizing cues utilize similar signaling mechanisms as Robo4.   
Although hypercytokinemia can be a significant source of pathologic damage, the 
exact number of patients that are hospitalized or die from the indirect effects of cytokine 
storm is unknown.  This is an interesting point on which to speculate.  For example, 
sepsis, acute lung injury/acute respiratory distress syndrome, and multiple organ 
dysfunction syndrome are characterized by cytokine storm and are significant sources of 
morbidity and mortality7.  The exaggerated cytokine response destabilizes the vasculature 
resulting in increased vascular permeability, organ failure, and ultimately death.  Perhaps 
through blunting the host vascular response to cytokines a significant advance in 
combating these diseases may be made. 
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The second contribution is to our understanding of signaling events downstream 
of Robo4 activation.  We found that administration of Slit to endothelial cells in vitro 
significantly increased VE-cadherin and p120-catenin cell surface localization as 
measured by immunofluoresence and membrane fractionation1.  Slit enhanced a p120-
catenin/VE-cadherin interaction, an interaction important in preventing internalization of 
VE-cadherin and its removal from the cell surface.  This interaction was maintained in 
the presence of interleukin-1β (IL-1β) and Slit administration did indeed inhibit IL-1β-
induced internalization of VE-cadherin.  Since one of the ultimate endpoints of cytokine-
induced permeability is the dissolution of VE-cadherin cell-cell interactions, Robo4 
activation provides a broad vascular stabilizing signal against multiple permeability 
inciting agents. 
Previous experiments performed in our lab by Chris Jones or in collaboration with 
Naoyuki Nishiya defined the immediate proximal signaling events that result from Robo4 
activation8.  First, paxillin is recruited to a small fragment of the Robo4 cytoplasmic 
domain known as the paxillin interaction motif.  Paxillin binds via the Lim4 domain and 
recruits GIT1, an Arf GTPase activating protein (Arf-GAP).  GIT1 recruitment 
accelerates the conversion of Arf6-GTP to Arf6-GDP resulting in the inactivation of 
Arf6.  While Arf6 is known to regulate epithelial cadherin (E-cadherin) cell surface 
localization, a role in VE-cadherin cell surface localization has yet to be fully defined.  
Additional experiments conducted by Weiquan Zhu in our lab have cemented this 
relationship.  Knockdown of Arf6 expression by siRNA in endothelial cells results in 
increased cell surface localization of VE-cadherin.  Conversely, siRNA knockdown of 
GIT1 results in decreased cell surface localization of VE-cadherin and increased 
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permeability.  Interestingly, these findings demonstrate that there is basal, tonic control of 
VE-cadherin localization in the cell and that this is controlled by GIT1 and Arf6.  Taken 
together, these data define a critical link between proximal signaling events of Robo4 
activation such as paxillin and GIT1 recruitment all the way to VE-cadherin cell surface 
presentation. 
In moving towards applying what we have learned into a clinical application, it is 
important to note that protein therapeutics are difficult and expensive to both produce and 
administer.  A small molecule inhibitor approach may be simpler and more effective.  
Having fully characterized the signaling cascade downstream of Robo4 activation we 
have identified Arf6 as a candidate target.  Previous work has defined a small molecule 
inhibitor of Arf guanine nucleotide exchange factors (Arf-GEFs) known as secinH39.  
Inhibition of Arf-GEFs results in the inactivation of Arf6, similar to Robo4-dependent 
Slit signaling.  To validate such an approach one needs to corroborate a previously 
demonstrated effect of Slit in vivo.  We previously demonstrated that Robo4-dependent 
Slit signaling limits retinal and choroidal vascular disease in mouse models of 
proliferative retinopathy and wet macular degeneration10.  In this dissertation, we have 
found that secinH3 is also effective at reducing neovascularization in these models, thus 
phenocopying the effect of Robo4-dependent Slit signaling8.  Therefore, using a small 
molecule inhibitor approach targeting Arf6 activation may prove effective in clinical 
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